These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 11956142)

  • 1. Follistatin-related protein and follistatin differentially neutralize endogenous vs. exogenous activin.
    Sidis Y; Tortoriello DV; Holmes WE; Pan Y; Keutmann HT; Schneyer AL
    Endocrinology; 2002 May; 143(5):1613-24. PubMed ID: 11956142
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follistatin-related protein (FSRP): a new member of the follistatin gene family.
    Schneyer A; Tortoriello D; Sidis Y; Keutmann H; Matsuzaki T; Holmes W
    Mol Cell Endocrinol; 2001 Jun; 180(1-2):33-8. PubMed ID: 11451569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparin and activin-binding determinants in follistatin and FSTL3.
    Sidis Y; Schneyer AL; Keutmann HT
    Endocrinology; 2005 Jan; 146(1):130-6. PubMed ID: 15471966
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of follistatin domains in follistatin biological action.
    Keutmann HT; Schneyer AL; Sidis Y
    Mol Endocrinol; 2004 Jan; 18(1):228-40. PubMed ID: 14563935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG).
    Schneyer A; Schoen A; Quigg A; Sidis Y
    Endocrinology; 2003 May; 144(5):1671-4. PubMed ID: 12697670
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary activin receptor subtypes and follistatin gene expression in female rats: differential regulation by activin and follistatin.
    Dalkin AC; Haisenleder DJ; Yasin M; Gilrain JT; Marshall JC
    Endocrinology; 1996 Feb; 137(2):548-54. PubMed ID: 8593801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential response to exogenous and endogenous activin in a human ovarian teratocarcinoma-derived cell line (PA-1): regulation by cell surface follistatin.
    Delbaere A; Sidis Y; Schneyer AL
    Endocrinology; 1999 Jun; 140(6):2463-70. PubMed ID: 10342830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential actions of follistatin and follistatin-like 3.
    Schneyer A; Sidis Y; Xia Y; Saito S; del Re E; Lin HY; Keutmann H
    Mol Cell Endocrinol; 2004 Oct; 225(1-2):25-8. PubMed ID: 15451564
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biological activity of follistatin isoforms and follistatin-like-3 is dependent on differential cell surface binding and specificity for activin, myostatin, and bone morphogenetic proteins.
    Sidis Y; Mukherjee A; Keutmann H; Delbaere A; Sadatsuki M; Schneyer A
    Endocrinology; 2006 Jul; 147(7):3586-97. PubMed ID: 16627583
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic regulation of pituitary follistatin messenger ribonucleic acids during the rat estrous cycle.
    Halvorson LM; Weiss J; Bauer-Dantoin AC; Jameson JL
    Endocrinology; 1994 Mar; 134(3):1247-53. PubMed ID: 8119165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell.
    Sugino K; Kurosawa N; Nakamura T; Takio K; Shimasaki S; Ling N; Titani K; Sugino H
    J Biol Chem; 1993 Jul; 268(21):15579-87. PubMed ID: 8340384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased follistatin (activin-binding protein) gene expression in rat anterior pituitary tissue after ovariectomy may be mediated by pituitary activin.
    DePaolo LV; Mercado M; Guo Y; Ling N
    Endocrinology; 1993 May; 132(5):2221-8. PubMed ID: 8477666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Follistatin and its role as an activin-binding protein.
    Sugino H; Sugino K; Hashimoto O; Shoji H; Nakamura T
    J Med Invest; 1997 Aug; 44(1-2):1-14. PubMed ID: 9395712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A two-site chemiluminescent assay for activin-free follistatin reveals that most follistatin circulating in men and normal cycling women is in an activin-bound state.
    McConnell DS; Wang Q; Sluss PM; Bolf N; Khoury RH; Schneyer AL; Midgley AR; Reame NE; Crowley WF; Padmanabhan V
    J Clin Endocrinol Metab; 1998 Mar; 83(3):851-8. PubMed ID: 9506739
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activin-A regulates follistatin secretion from cultured rat anterior pituitary cells.
    Bilezikjian LM; Corrigan AZ; Vaughan JM; Vale WM
    Endocrinology; 1993 Dec; 133(6):2554-60. PubMed ID: 8243277
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors.
    de Winter JP; ten Dijke P; de Vries CJ; van Achterberg TA; Sugino H; de Waele P; Huylebroeck D; Verschueren K; van den Eijnden-van Raaij AJ
    Mol Cell Endocrinol; 1996 Jan; 116(1):105-14. PubMed ID: 8822271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and characterization of binding proteins for inhibin and activin in human serum and follicular fluids.
    Krummen LA; Woodruff TK; DeGuzman G; Cox ET; Baly DL; Mann E; Garg S; Wong WL; Cossum P; Mather JP
    Endocrinology; 1993 Jan; 132(1):431-43. PubMed ID: 7678220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pituitary follistatin and inhibin subunit messenger ribonucleic acid levels are differentially regulated by local and hormonal factors.
    Bilezikjian LM; Corrigan AZ; Blount AL; Vale WW
    Endocrinology; 1996 Oct; 137(10):4277-84. PubMed ID: 8828487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum.
    Schneyer AL; Rzucidlo DA; Sluss PM; Crowley WF
    Endocrinology; 1994 Aug; 135(2):667-74. PubMed ID: 8033815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The heparin binding site of follistatin is involved in its interaction with activin.
    Sumitomo S; Inouye S; Liu XJ; Ling N; Shimasaki S
    Biochem Biophys Res Commun; 1995 Mar; 208(1):1-9. PubMed ID: 7887917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.